Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01238_DB06414_nanopub.RAqsitJwTsjEJ2GXukjiOPH1b3OWxIch88LferEoStbbY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01238_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01238_DB06414 label "DDI between Aripiprazole and Etravirine - Ariprazole, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to increase the dose of oral aripiprazole to maintain therapeutic efficacy, and to adjust the dose of aripiprazole appropriately when the dose of etravirine is altered. [drugbank_resource:DB01238_DB06414]" assertion.
- drugbank_resource:DB01238_DB06414 identifier "drugbank_resource:DB01238_DB06414" assertion.
- drugbank_resource:DB01238_DB06414 title "DDI between Aripiprazole and Etravirine - Ariprazole, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to increase the dose of oral aripiprazole to maintain therapeutic efficacy, and to adjust the dose of aripiprazole appropriately when the dose of etravirine is altered." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01238_DB06414 assertion.
- drugbank:DB01238 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01238_DB06414 assertion.